Stock·NYSE·Industrials
Robert Half Inc. (RHI)
- Market cap
- $3.41B
- P/E
- 29.90
- Dividend yield
- 7.08%
- Street target
- $31.00median of 11 analysts
- 52-week range
- $21.83 $46.70
The short version
Where RHI stands today, in four lines, and what CleaRank Financial AI makes of it.
RHI at a glance
Robert Half Inc. (RHI): Hold, 44/100 on CleaRank's AI score.
- Trend Mixed: the price is above its 200-day but below its 50-day moving average ($31.61 and $39.38).
- Earnings RHI beat estimates in 2 of its last 3 quarters, yet fell the next day after 1 of those beats.
- Insiders Insiders sold $188K and made no open-market purchases over the last 18 months.
- Valuation P/E of 29.9 against 34.0 for the Industrials sector: broadly in line with peers (-12%).
Figures as of October 17, 2026.
CleaRank Financial AI
Robert Half Inc. (RHI) earns a Hold rating from CleaRank, with a model score of 44/100.
Its earnings record is the biggest contributor, having beaten estimates in 2 of its last 3 reports, and the most recent available report beat the estimate by 6.67%. Momentum is the largest drag: the 14-day RSI is 32.8, in the bearish zone, and the MACD line is negative. Trend signals are mixed, since RHI sits 15.42% below its 50-day average of $39.38 yet 5.38% above its 200-day average of $31.61. Across the past year, the price climbed 3.96%.
Only on CleaRank
Figures we compute ourselves from RHI's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
2/4Price above its 50-day average ›
The price of $33.31 is 15.4% below the 50-day simple moving average of $39.38.Price above its 200-day average ›
The price is 5.4% above the 200-day simple moving average of $31.61.50-day average above the 200-day ›
The 50-day average ($39.38) is 24.6% above the 200-day average ($31.61), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 46% of its 52-week range, between $21.83 and $46.70.
RHI share price
Pick a period: each tab shows how far RHI has moved over it, to the last close.
Today's trading
Where RHI sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
5/5P/E below the sector median ›
The trailing P/E of 29.90 is 12.0% below the Industrials median of 34.0.P/S below the sector median ›
The price-to-sales ratio of 0.67 is 83.4% below the sector median of 4.0.Profitable over the last 12 months ›
Net income over the last 12 months was $114.8M on revenue of $5.3B, a net margin of 2.2%.Beat estimates in most recent reports ›
RHI beat the EPS estimate in 2 of its last 3 reports.Pays a dividend ›
The trailing dividend yield is 7.08%, or $2.36 a share a year.
Key statistics
The headline figures for RHI.
As of October 17, 2026, RHI trades at $33.31, with a market value of $3.41B, a P/E ratio of 29.90 and a dividend yield of 7.08%.
What the numbers say
CleaRank Financial AI's reading of RHI's valuation, growth and risks.
RHI trades at 29.90 times trailing earnings, which is 12.0% below the Industrials median of 34.0. The peer comparison on this page calls that P/E broadly in line with peers. On sales, the P/S of 0.67 sits 83.3% below the sector median of 4.0. Market value stands at $3.4B, and trailing earnings are $1.15 a share.
Revenue fell 2.40% over the latest year, which is 14.1 percentage points behind the 11.7% median for Industrials. Profitability shows a net margin of 2.17% and an operating margin of -4.66%. It reports a return on equity of 9.11%, below the sector median of 17.8%. It also reports debt-to-equity of 0.20 and a trailing dividend yield of 7.08% ($2.36 a share a year).
The most recent available report in our data, dated January 29, 2026, showed EPS of $0.32 against an estimate of $0.3, a beat of 6.67% above the estimate. Investors responded quickly: the stock climbed 27.76% in the next session.
The earnings record shows 2 beats in 3 reports; even so, 1 of those 2 beats was followed by a lower share price the next session. Earlier, the stock fell 6.04% after the July 23, 2025 report, a beat of 2.50%. Looking ahead, analysts expect EPS of $1.26 this fiscal year (a decline of 4.9%) and $1.97 the year after (growth of 56.1%).
On a typical day the price of RHI shifts by 2.49%, the 30-day standard deviation of its daily returns. The price is 28.67% below its 52-week high of $46.70. Over the last 18 months, insider sales totalled $188K with no open-market purchases; planned sales and tax sales on vesting shares make selling a weaker signal than buying.
RHI against the Industrials sector
How RHI compares with the median Industrials stock CleaRank tracks.
Price to earnings vs sector: Valuation is broadly in line with sector peers (-12% difference), suggesting fair market pricing relative to industry standards.
Return vs XLI: Since May 6, 2025, RHI has lost 23.2% against a gain of 25.6% for XLI.
Performance against XLI
RHI and the Industrials sector fund over the same days.
Revenue and earnings
How much RHI sells, and how much of it becomes profit.
Revenue growth: Revenue fell 7.2% in FY2025 to $5.4B, from $5.8B a year earlier.
Profit margin: The net margin was 2.5% in FY2025, down from 4.3% the year before.
Profitable: RHI earned $133M in FY2025.
Earnings reality check
Did RHI beat what analysts expected, and how did the stock react?
Earnings record: RHI beat the analyst estimate in 2 of the last 3 quarters.
Market reaction: The stock fell in the first session after 1 of those 2 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Jan 29, 2026after close | $0.30 | $0.32 | +6.67% | +27.76% | +16.21% |
| Oct 22, 2025after close | $0.43 | $0.43 | +0.00% | -1.25% | -7.39% |
| Jul 23, 2025after close | $0.40 | $0.41 | +2.50% | -6.04% | -11.67% |
Reports after January 29, 2026 are not yet in our data.
As of October 17, 2026, RHI has beaten the analyst EPS estimate in 2 of its last 3 reported quarters and fell in the first trading session after 1 of those beats; its most recent report in our data, on January 29, 2026, came in 6.67% above the estimate and the stock moved +27.76% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 32.8, showing bearish momentum without being oversold.RSI above 50 ›
An RSI of 32.8 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of RHI
The score, the reasoning behind it, and what could move the price next.
RHI trades between its two moving averages. At $33.31, the price is 5.38% above its 200-day average of $31.61 but 15.42% below its 50-day average of $39.38. Within its 52-week range, which runs from $21.83 to $46.70, the price sits at 46%.
A recent pullback sits inside a stronger longer record: the price fell 10.19% over the past month, fell 20.31% over the past three months and rose 3.96% over the past year. On momentum, the 14-day RSI reads 32.8, in the bearish zone, above the oversold line, with the MACD line negative. The price fell 3.14% in the last session on volume 30.3% below its average.
Earnings beat ›
The January 29, 2026 report beat the EPS estimate by 6.67%, and the share price rose 27.76% in the first session after it.
Source: Earnings report, January 29, 2026Analyst upgrade ›
William Blair upgraded it to Outperform from Market Perform on April 21, 2026.
Source: Analyst action, William Blair, April 21, 2026
Rating reaffirmed ›
Goldman Sachs kept its Sell rating on July 24, 2026.
Source: Analyst action, Goldman Sachs, July 24, 2026
- Keep an eye on the two closest levels: the 20-day EMA at $35.60 sits above the price, and the 200-day SMA at $31.61 sits below it.
- A 14-day RSI of 32.8 places RHI in the bearish zone, and the MACD line is negative. Readings above 70 or below 30 would point to stretched momentum.
- RHI beat estimates in 2 of the last 3 reports, and after the January 29, 2026 report the share price climbed 27.76% in the first session.
RHI's trend is mixed. The price is above the 200-day average of $31.61 but under the 50-day average of $39.38. Closing above the 50-day would flip both signals to up, while closing below the 200-day would flip both to down. For now the price is wedged between the 200-day SMA at $31.61 below and the 20-day EMA at $35.60 above.
RHI's RSI is in the bearish zone, a reading that argues against a fast rebound.
Technical indicators
Momentum and trend for RHI, from its daily closes.
As of October 17, 2026, with RHI at $33.31, its 14-day RSI is 32.8 (showing bearish momentum without being oversold), its 50-day simple moving average is $39.38 and its 200-day is $31.61.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What RHI moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, RHI's 1-year correlation of daily returns is +0.30 with S&P 500 (SPY), +0.18 with Nasdaq 100 (QQQ), +0.05 with Bitcoin (BTC) and -0.18 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
0/3Most analysts rate it a buy ›
4 of 11 analysts rate it a buy or strong buy, 3 a hold and 4 a sell.Median target above the price ›
The median 12-month target of $31.00 is 6.9% below the price.More buy ratings than three months ago ›
4 of 11 rate it a buy now, against 4 of 11 three months ago.
RHI Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jul 24, 2026 | Goldman Sachs | Maintains | Sell |
| Jul 22, 2026 | Truist Securities | Maintains | Buy |
| Jul 14, 2026 | Goldman Sachs | Maintains | Sell |
| Apr 21, 2026 | William Blair | Upgrade | Outperform |
As of October 17, 2026, 11 Wall Street analysts cover RHI: 4 rate it a buy or strong buy, 3 a hold and 4 a sell or strong sell. Their 12-month price targets range from $20.00 to $50.00, with a median of $31.00, 6.9% below the price of $33.31.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
RHI trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from RHI's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much RHI tends to move, against the market and on its own.
The long record
RHI's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
0/4Average daily move under 2% ›
The price has moved 2.49% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 78.0%, from February 2022 to March 2026; the price is still 66.6% below that peak.Most 1-year holds ended higher ›
48% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $11,789, against $42,055 in the S&P 500 (SPY).
RHI Drawdowns & Recovery
As of October 17, 2026, RHI's worst peak-to-trough fall over the last 10 years with dividends reinvested was -78.0% (February 2022 to March 2026); it is still 66.6% below that peak, and 48% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into RHI in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: RHI trailed the S&P 500 over this period: $11,789 against $42,055.
A $10,000 investment in RHI in October 2016 would be worth about $11,789 today with dividends reinvested, compared with about $42,055 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to RHI, and which have not.
Strongest month, November: an average of +8.75%, up in 9 of 10 years.
Weakest month, March: an average of -3.90%, up in 1 of 10 years.
This month, October: has averaged -1.27%, up in 6 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, RHI's strongest calendar month has been November (average +8.75%, up in 9 of 10 years) and its weakest March (average -3.90%, up in 1 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in RHI, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in RHI today could grow to about $12,653 by 2036 in the base case, with a 90th-percentile outcome near $53,067 and a 10th-percentile outcome around $3,017. The simulation models price only; at today's 7.08% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
RHI Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $36.60 for RHI by 2030 in the base case, from $33.31 today (1.1x over 4 years). The 10th-percentile path ends near $14.78. These are outcomes of a Monte Carlo simulation run on RHI's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $21.67 | $34.10 | $53.66 | |
| 2028 | $18.39 | $34.92 | $66.29 | |
| 2029 | $16.30 | $35.75 | $78.39 | |
| 2030 | $14.78 | $36.60 | $90.62 | |
| 2031 | $13.60 | $37.47 | $103 |
Method: a lognormal simulation of RHI's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
RHI insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: No insider bought RHI shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 17, 2026, RHI insiders reported 1 open-market sale worth $188K and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 13, 2026 | Jana Barsten
Director
|
Grant | 10.8K | - |
| May 13, 2026 | Julia Lynn Coronado
Director
|
Grant | 10.8K | - |
| May 13, 2026 | Marc H Morial
Director
|
Grant | 10.8K | - |
| May 13, 2026 | Robert J Pace
Director
|
Grant | 10.8K | - |
| May 13, 2026 | Frederick A Richman
Director
|
Grant | 10.8K | - |
| May 13, 2026 | Marnie Huss Wilking
Director
|
Grant | 10.8K | - |
| Mar 23, 2026 | Michael C Buckley
Chief Financial Officer
|
Grant | 57.3K | - |
| Mar 23, 2026 | Paul F Gentzkow
Officer
|
Grant | 151.2K | - |
| Mar 23, 2026 | Robert W Glass
Officer
|
Grant | 20.6K | - |
| Mar 23, 2026 | Harold M Messmer Jr
Chairman of the Board
|
Grant | 45.0K | - |
| Mar 23, 2026 | Joseph A Tarantino
Officer
|
Grant | 81.3K | - |
| Mar 23, 2026 | Michael Keith Waddell
Chief Executive Officer
|
Grant | 179.8K | - |
| Oct 28, 2025 | Dirk A Kempthorne
Director
|
Sell | 6.5K | $187.8K |
| May 14, 2025 | Jana Barsten
Director
|
Grant | 5.9K | - |
| May 14, 2025 | Julia Lynn Coronado
Director
|
Grant | 5.9K | - |
| May 14, 2025 | Dirk A Kempthorne
Director
|
Grant | 5.9K | - |
| May 14, 2025 | Marc H Morial
Director
|
Grant | 5.9K | - |
| May 14, 2025 | Robert J Pace
Director
|
Grant | 5.9K | - |
| May 14, 2025 | Frederick A Richman
Director
|
Grant | 5.9K | - |
| May 14, 2025 | Marnie Huss Wilking
Director
|
Grant | 5.9K | - |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.